HomeAPUS • NYSEAMERICAN
add
Apimeds Pharmaceuticals US Inc
Previous close
$1.90
Day range
$1.80 - $1.95
Year range
$1.44 - $4.00
Market cap
22.34M USD
Avg Volume
129.49K
P/E ratio
-
Dividend yield
-
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 364.37K | 34.09% |
Net income | -402.40K | -35.73% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 250.34K | 69.86% |
Total assets | 259.90K | 64.79% |
Total liabilities | 2.02M | 378.41% |
Total equity | -1.76M | — |
Shares outstanding | 11.58M | — |
Price to book | -8.64 | — |
Return on assets | -667.44% | — |
Return on capital | 123.27% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -402.40K | -35.73% |
Cash from operations | -20.31K | 92.28% |
Cash from investing | — | — |
Cash from financing | 267.20K | — |
Net change in cash | 246.89K | 193.84% |
Free cash flow | 103.81K | 160.27% |
About
Founded
2020
Headquarters
Website
Employees
2
